Cargando…

SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE

INTRODUCTION: SARS-CoV-2 infection leads to a wide spectrum of clinical disease characterized by hyperinflammation. The role of eosinophils in SARS-CoV-2 infection is unclear, and rare eosinophilic complications have been reported. We present a case of severe hypereosinophilia developing concomitant...

Descripción completa

Detalles Bibliográficos
Autores principales: Eremija, J., Domit, N. Odisho, Carr, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646432/
http://dx.doi.org/10.1016/j.anai.2022.08.985
_version_ 1784827165531963392
author Eremija, J.
Domit, N. Odisho
Carr, T.
author_facet Eremija, J.
Domit, N. Odisho
Carr, T.
author_sort Eremija, J.
collection PubMed
description INTRODUCTION: SARS-CoV-2 infection leads to a wide spectrum of clinical disease characterized by hyperinflammation. The role of eosinophils in SARS-CoV-2 infection is unclear, and rare eosinophilic complications have been reported. We present a case of severe hypereosinophilia developing concomitantly with SARS-CoV-2 infection, leading to multiple end-organ damage to the extent not previously described. CASE DESCRIPTION: 24-year-old female with bipolar disorder presented with neck/throat and muscle pain in January of 2021, during an Omicron variant wave of SARS-CoV-2. Initial testing detected positive SARS-CoV-2 PCR, leukocytosis 37.7 × 10(3)/μL and eosinophilia 24.39 × 10(3)/μL. Over the next month, patient's leukocytes and eosinophils persistently increased to maximum 96.5 and 71.5 × 10(3)/μL respectively. She developed muscle weakness and vision changes. Physical exam showed forearm edema, tremors, and splinter hemorrhages. Imaging confirmed myocarditis, multiple strokes, with regional myositis, cellulitis, and tenosynovitis. Lab workup was negative for other infections, ANCA vasculitides, KIT-mutation, tryptase, vitamin B12, FISH panel for myeloproliferative disorders, and next generation sequencing (PDGFRA, PDGFRB, FGFR1, FGFR2, JAK2). Bone marrow biopsy demonstrated leukocytosis, absolute eosinophilia with reactive features. She was treated with hydroxyurea and systemic steroids, after which the eosinophil count declined and she started to note clinical improvement. At this time, she has successfully transitioned to mepolizumab monotherapy. DISCUSSION: Hypereosinophilia and eosinophilic inflammation have been described following SARS-CoV-2 infection and vaccination. Hypereosinophilia can inflict end-organ damage, but to our knowledge this is the first reported case of severe hypereosinophilia coinciding with COVID-19, causing this extensive degree of systemic thrombotic and myopathic disease. Whether SARS-CoV-2 infection was a coincidental or causative, remains uncertain.
format Online
Article
Text
id pubmed-9646432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96464322022-11-14 SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE Eremija, J. Domit, N. Odisho Carr, T. Ann Allergy Asthma Immunol M365 INTRODUCTION: SARS-CoV-2 infection leads to a wide spectrum of clinical disease characterized by hyperinflammation. The role of eosinophils in SARS-CoV-2 infection is unclear, and rare eosinophilic complications have been reported. We present a case of severe hypereosinophilia developing concomitantly with SARS-CoV-2 infection, leading to multiple end-organ damage to the extent not previously described. CASE DESCRIPTION: 24-year-old female with bipolar disorder presented with neck/throat and muscle pain in January of 2021, during an Omicron variant wave of SARS-CoV-2. Initial testing detected positive SARS-CoV-2 PCR, leukocytosis 37.7 × 10(3)/μL and eosinophilia 24.39 × 10(3)/μL. Over the next month, patient's leukocytes and eosinophils persistently increased to maximum 96.5 and 71.5 × 10(3)/μL respectively. She developed muscle weakness and vision changes. Physical exam showed forearm edema, tremors, and splinter hemorrhages. Imaging confirmed myocarditis, multiple strokes, with regional myositis, cellulitis, and tenosynovitis. Lab workup was negative for other infections, ANCA vasculitides, KIT-mutation, tryptase, vitamin B12, FISH panel for myeloproliferative disorders, and next generation sequencing (PDGFRA, PDGFRB, FGFR1, FGFR2, JAK2). Bone marrow biopsy demonstrated leukocytosis, absolute eosinophilia with reactive features. She was treated with hydroxyurea and systemic steroids, after which the eosinophil count declined and she started to note clinical improvement. At this time, she has successfully transitioned to mepolizumab monotherapy. DISCUSSION: Hypereosinophilia and eosinophilic inflammation have been described following SARS-CoV-2 infection and vaccination. Hypereosinophilia can inflict end-organ damage, but to our knowledge this is the first reported case of severe hypereosinophilia coinciding with COVID-19, causing this extensive degree of systemic thrombotic and myopathic disease. Whether SARS-CoV-2 infection was a coincidental or causative, remains uncertain. Published by Elsevier Inc. 2022-11 2022-11-10 /pmc/articles/PMC9646432/ http://dx.doi.org/10.1016/j.anai.2022.08.985 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle M365
Eremija, J.
Domit, N. Odisho
Carr, T.
SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE
title SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE
title_full SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE
title_fullStr SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE
title_full_unstemmed SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE
title_short SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE
title_sort sars-cov-2 infection associated with new severe hypereosinophilia and multiple organ damage
topic M365
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646432/
http://dx.doi.org/10.1016/j.anai.2022.08.985
work_keys_str_mv AT eremijaj sarscov2infectionassociatedwithnewseverehypereosinophiliaandmultipleorgandamage
AT domitnodisho sarscov2infectionassociatedwithnewseverehypereosinophiliaandmultipleorgandamage
AT carrt sarscov2infectionassociatedwithnewseverehypereosinophiliaandmultipleorgandamage